The CPS1 gene was identified as a virulence factor in the maize pathogen Cochliobolus heterostrophus. Hypothesizing that the homologous gene in Coccidioides posadasii could be important for virulence, we created a ⌬cps1 deletion mutant which was unable to cause disease in three strains of mice (C57BL/6, BALB/c, or the severely immunodeficient NOD-scid,␥c null [NSG]). Only a single colony was recovered from 1 of 60 C57BL/6 mice following intranasal infections of up to 4,400 spores. Following administration of very high doses (10,000 to 2.5 ؋ 10 7 spores) to NSG and BALB/c mice, spherules were observed in lung sections at time points from day 3 to day 10 postinfection, but nearly all appeared degraded with infrequent endosporulation. Although the role of CPS1 in virulence is not understood, phenotypic alterations and transcription differences of at least 33 genes in the ⌬cps1 strain versus C. posadasii is consistent with both metabolic and regulatory functions for the gene. The in vitro phenotype of the ⌬cps1 strain showed slower growth of mycelia with delayed and lower spore production than C. posadasii, and in vitro spherules were smaller. Vaccination of C57BL/6 or BALB/c mice with live ⌬cps1 spores either intranasally, intraperitoneally, or subcutaneously resulted in over 95% survival with mean residual lung fungal burdens of <1,000 CFU from an otherwise lethal C. posadasii intranasal infection. Considering its apparently complete attenuation of virulence and the high degree of resistance to C. posadasii infection when used as a vaccine, the ⌬cps1 strain is a promising vaccine candidate for preventing coccidioidomycosis in humans or other animals.
C
occidioides species (C. immitis and C. posadasii) are the causative agents of coccidioidomycosis (valley fever), an important emerging disease endemic to the southwestern United States and elsewhere in the Western Hemisphere (1-3). Inhalation of a 2-to 4-m arthroconidium (spore) initiates a respiratory infection and grows as a unique parasitic phase structure, the spherule, to 80 to 100 m in diameter (4) . During spherule maturation, which in mice takes approximately 4 days, internal cell division and septation results in hundreds of endospores that, if released, can reinitiate spherule growth in the infected tissue. Although many infections resolve without medical intervention, about 40% of infections cause respiratory illnesses that often last weeks to many months (5) . In a small percentage of patients, infection disseminates from the lungs hematogenously to produce progressive, protracted, and even fatal complications. With or without clinical illness, most infections produce lifelong immunity to a second coccidioidal infection, and it is this observation that suggests a preventative vaccine could be developed (6) .
Interest in CPS1 came first from a search for general virulence factors in the maize pathogen Cochliobolus heterostrophus. In this and other ascomycete cereal grain pathogens, deletion of the CPS1 gene results in reduced virulence on host plants with production of smaller lesions (7) . We hypothesized that disruption of the homolog of CPS1 in Coccidioides might also alter its pathogenicity. In this report, we show that deletion of CPS1 by gene replacement (⌬cps1 mutant) results in a complete attenuation of the pathogenicity exhibited by wild-type C. posadasii for mice. Moreover, mice vaccinated with the live ⌬cps1 mutant become highly resistant to a subsequent respiratory infection with wild-type C. posadasii that otherwise would be lethal. The striking safety and efficacy demonstrated in these studies support the ⌬cps1 strain as a promising vaccine candidate to prevent coccidioidomycosis in humans and other mammals. In addition, since we found that the capacity of the ⌬cps1 strain to grow into arthroconidia (spores) is only slightly reduced, this mutant may readily lend itself to manufacturing processes and formulations that would be needed for a live spore-based vaccine to become clinically useful.
Spherules were grown in vitro in modified Converse medium at 37°C, 20% CO 2 with shaking at 180 rpm as described previously (9) .
Mice. Six-to 8-week-old female C57BL/6NHsd (B6) and BALB/ cAnNHsd (BALB/c) mice were purchased from Harlan Sprague Dawley (renamed Envigo, Indianapolis, IN). They were housed and utilized according to National Institutes of Health guidelines. NOD.Cg-Prkdc scid
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tm1Wjl /SzJ (NSG) mice were originally obtained from Leonard Schultz, Jackson Laboratory, and bred onsite under specific-pathogen free (SPF) conditions. NSG mice lack mature T cells, B cells, and functional NK cells and are also deficient in cytokine signaling (10) ; because of their severe immunodeficiency, they were housed under SPF conditions until transfer into the animal BSL3 laboratory for infection with the ⌬cps1 mutant. All studies were conducted with the approval of the Institutional Animal Care and Use Committee at the University of Arizona.
Creation of a CPS1 gene deletion mutant in C. posadasii. The CPS1 gene of Coccidioides (GenBank accession number XM_001243861.2; Broad Institute) was identified using the C. heterostrophus sequence (GenBank accession number AF332878) (7) . A CPS1 gene deletion cassette for C. posadasii was constructed in multiple steps using primers listed in Table 1 . DNA from C. posadasii was used as the template to generate PCR fragments representing 1.1 kb of the 5= flanking region and 1.2 kb of the 3= flanking region of the CPS1 gene using primers OAM 1190 and OAM 1192 as well as OAM 1193 and OAM 1194, respectively. Primers OAM 1192 and OAM 1193 contain sequences complementary to the ends of the hygromycin resistance gene cassette (hphB) of plasmid pCB1004 (11) . The hygromycin (hphB) gene was amplified from plasmid pCB1004 using primers OAM 597 and OAM 598 (12) . The PCR products of the CPS1 5= and 3= flanking sequences were mixed with that of the hphB gene and amplified with nested primers OAM 1191 and 1195, containing EcoRI sites, using double-joint PCR (13) . The resulting PCR product was then ligated into pGEM-T Easy (Promega, Madison, WI). The construct, designated pAM1567, was verified by restriction analysis and PCR, and the hphB insert gene of the plasmid was sequenced to determine that no mutations had been introduced. The gene replacement construct from pAM1567, containing CPS1 5=-untranslated region (UTR)-hphB-CPS1 3=UTR, was cloned into the binary vector pAM1145 as an EcoRI fragment, producing plasmid pAM1594. Plasmid pAM1594 was transformed into Agrobacterium tumefaciens strain EHA105 (14) by electroporation, and the resulting strain was named A1594.
C. posadasii was transformed using A. tumefaciens strain A1594 as described previously (12) . Briefly, 1 ϫ 10 7 spore germlings and 1 ϫ 10 9 induced A. tumefaciens cells were mixed and dispersed onto six 0.45-m, 82-mm-diameter nitrocellulose filters (Millipore Corporation, Bedford, MA, USA) on plates containing AB induction media. Following cocultivation at room temperature for 48 h, the nitrocellulose filters were transferred to selection plates supplemented with 50 g/ml hygromycin (selection for transformed strains) and 100 g/ml kanamycin (counterselection to prevent growth of A. tumefaciens). Transformants were isolated after incubation at room temperature for 1 to 2 weeks and grown on selection plates for sporulation. Monoconidial isolates were selected via two conidial passages as described previously (12) . Twenty-seven hygromycin-resistant transformants were analyzed by PCR to test for the presence of the hphB gene, and 20 of these were subjected to Southern hybridization using the hph gene, a CPS1 gene internal probe, and 5= and 3= flanking sequences as probes. Probes for hybridization included the hphB gene, generated by PCR amplification from plasmid pCB1004 using primers OAM 597 and OAM 598, an internal fragment of CPS1 generated by amplification from C. posadasii genomic DNA using primers OAM 1288 and OAM 1289, and a 5= flanking region fragment generated using C. posadasii DNA as the template with primers OAM 1190 and OAM 1192 (Table 1) . When hybridized with the hphB gene probe, seven strains (11, 19, 28, 30, 47, 52 , and 53) contained the predicted 10.2-kb EcoRI fragment, indicative of a homologous gene replacement event defined by the EcoRI sites that are present in the 5= and 3= flanking regions. The transformant DNA blots were hybridized with an internal probe of the CPS1 gene, and as predicted, the putative gene replacement strains (11, 19, 28, 30, 47, 52 , and 53) lacked the CPS1 gene, while others contained the 5.1-kb EcoRI fragment that was present in C. posadasii.
Ten transformants, including six putative gene replacement strains (11, 19, 28, 30, 52 , and 53) and four putative ectopic strains (6, 13, 45 , and 48), were analyzed further. A 5= flanking region probe was used to confirm replacement of the CPS1 gene with hphB in strains 11, 19, 28, 30, 52 , and 53. In all of these strains, the 5= probe hybridized to the same 10.2-kb EcoRI fragment as the hphB probe, as predicted. The putative ectopic strains 6, 13, 45, and 48 contained two bands that hybridized to the 5= probe: a 5.1-kb hybridizing band, as seen with the CPS1 internal probe, identical to the band in C. posadasii, as well as an additional, variable-sized band identifying the ectopically introduced construct. These results indicate that strains 11, 19, 28, 30, 52 , and 53 each arose from a single homologous integration event of the CPS1 deletion cassette while strains 6, 13, 45, and 48 are ectopic transformants. Strains 19, 52 , and 53 were selected for in vivo virulence studies. Following these studies, strain 19 was used for further studies and is referred to here as the ⌬cps1 strain.
Measurements of in vitro growth. Radial growth of ⌬cps1 strain mycelia was compared to that of mycelia of C. posadasii by measuring colonial diameters following inoculation of plates with 6-mm-diameter agar plugs of young cultures. Triplicate plates of C. posadasii and ⌬cps1 strains in 2ϫ GYE were grown at room temperature and 37°C. Colony diameters were recorded daily for days 3 to 7 and day 14 postinoculation. Conidiation of the ⌬cps1 strain was compared to that of C. posadasii by plating ϳ1 ϫ 10 6 spores and allowing cultures to mature for 4 to 8 weeks at room temperature. Twelve to 20 plates were harvested and combined, and the spores were enumerated using hemocytometer counts and serial dilution plating.
In vitro spherule sizes of ⌬cps1 and C. posadasii strains were compared by harvesting spherules at 24-h intervals up to 120 h, fixing in 10% formaldehyde, and staining them with cotton blue. At least 50 spherules were measured with an ocular micrometer at each time point.
Effect of oxidative stress on C. posadasii and ⌬cps1 strains was assessed on medium containing H 2 O 2 (15) . Hydrogen peroxide from 2 mM to 20 mM was added to GYE media, and strains were grown at either room temperature or 37°C. Radial growth was measured as described above on days 3, 5, and 7.
Fungal metabolite analysis. For extraction of secreted metabolites, C. posadasii and ⌬cps1 strains were grown on 2ϫ GYE agar media. Four plates per strain were inoculated with mycelial plugs from the periphery of actively growing cultures and incubated at room temperature for 1 month. To extract metabolites, 10 ml of methanol was added to each plate and incubated for 5 min, and then the agar was cut into 0.5-cm cubes and transferred with the methanol to a 500-ml flask. An additional 60 ml of methanol was added to each flask and incubated with agitation for 4 h. The methanol extract was filtered through Whatman no. 1 paper to remove agar and then sterilized using a 0.22-m filter. Crude extracts were analyzed on thin-layer chromatography (TLC) plates using either hexaneethyl acetate (50:50) or 100% ethyl acetate as the solvent, or they were subjected to further purification. Extracts were purified by methanol evaporation followed by resuspension and partitioning between distilled water and ethyl acetate. Ethyl acetate extracts were dried, resuspended in methanol, and subjected to TLC analysis on silica gel 60 RP-18 F 254 plates. Extracts were separated using methanol or methanol-water mixtures (90: 10, 80:20, and 60:40) as solvent.
RNA-seq. To perform genome-wide transcriptome expression profiling (RNA-seq), spherules from C. posadasii and ⌬cps1 strains were prepared and RNA isolated (16) . Strains were grown in duplicate by inoculating 100 ml of modified Converse liquid medium with 3 ϫ 10 8 C. posadasii or ⌬cps1 strain freshly harvested spores and growing them at 38°C and 20% CO 2 , with shaking at 180 rpm for 48 h. Spherule RNAs were resuspended in diethyl pyrocarbonate-treated H 2 O prior to assessment of their quality and concentration with an Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA) and with the Quant-iT RiboGreen RNA assay kit (Life Technologies, Grand Island, NY).
RNA-seq was performed, in duplicate, on the C. posadasii and ⌬cps1 strain RNAs by 100-bp paired-end reads on an Illumina HiSeq2000 at the University of Arizona Genetics Core facility. Sequencing produced between 2.05 ϫ 10 7 and 2.37 ϫ 10 7 paired-end reads per library. Differential gene expression analysis was performed utilizing the Tuxedo 2.0 suite of programs hosted on the iPlant Cyberinfrastructure at the University of Arizona (17) . Gene identification was performed using the C. immitis RS annotated sequence provided by the Broad Institute (http://www .broadinstitute.org/scientific-community/science/projects/fungal -genome-initiative/coccidioides-genomes). These sequences are no longer available at the Broad site but are accessible via GenBank BioProject PRJNA46299.
Murine virulence studies. Pathogenicity of the ⌬cps1 strain was assessed in a series of studies using B6, BALB/c, and NSG mice. Initially, 8-week-old B6 mice were infected intranasally (i.n.) under ketamine (80 mg/kg of body weight)-xylazine (8 mg/kg) anesthesia as described previously (18) . Twelve mice per group were infected by intranasal insufflation of 30 l of spores suspended in 0.9% saline with doses ranging from 50 to 5,000 spores of three independent CPS1 deletion strains (19, 52 , and 53). As controls, B6 mice were given a lethal dose (50 spores) of C. posadasii. Two mice from each group were sacrificed at 14 days postinfection (p.i.) for histopathology, and the other 10 were maintained for 28 days or until they appeared moribund.
In a second experiment, six NSG mice received 1,030 spores of the ⌬cps1 strain. Two mice were sacrificed on day 6, with lungs fixed and processed for histopathology, and the other four were sacrificed on day 14 p.i. Two mice sacrificed on day 14 were processed for histopathology, and the entire lungs of the other two were cultured to assess fungal burden (19) .
BALB/c and NSG mice were further evaluated in histopathology studies to observe the fate of the ⌬cps1 strain. Two NSG and two BALB/c mice received 10,000 spores of the ⌬cps1 strain, and one mouse of each strain was euthanized on day 1 or day 3 p.i. and the lungs fixed for histopathology. In a final experiment, eight BALB/c mice were given 2.5 ϫ 10 7 spores i.n. and sacrificed on days 1 (n ϭ 2), 3 (n ϭ 1), 4 (n ϭ 1), 5 (n ϭ 2), 7 (n ϭ 1), and 10 (n ϭ 1) p.i., and the lungs were fixed for histopathology (19) .
Protection of mice against C. posadasii infection by ⌬cps1 mutant vaccination. Mice were primed, boosted 2 weeks later, and challenged intranasally 4 weeks following the boost. Control immunogens consisted of rAg2/PRA 1-106 -CSA with MPL-SE (25 g)/CpG (10 g) adjuvant as previously described for the protection control and adjuvant only as the negative control (20) . Groups of eight B6 mice were vaccinated with 50,000 viable spores of the ⌬cps1 strain, either subcutaneously (s.c.) or intraperitoneally (i.p.), or with control vaccines and then infected with 90 C. posadasii spores. Mice were sacrificed 2 weeks later and lung fungal burden quantitated; spleens were cultured whole to determine dissemination (20) . Groups of 10 BALB/c mice were vaccinated i.n. or s.c. with 10,000 viable spores of the ⌬cps1 strain or with control reagents and infected with 46 spores of C. posadasii. Mice were observed for survival for 28 days. Surviving mice were sacrificed and lungs and spleens cultured.
Histopathology. Lungs were fixed in 10% buffered formalin for a minimum of 24 h. For the B6 mouse virulence studies (2 mice per group), one slide (5-m section) from each mouse was stained with hematoxylin and eosin (H&E) for review. The NSG mice, given 1,030 spores, were sacrificed on days 6 and 14, and 5-m sections were cut through the entire lungs with every fifth section affixed to slides and stained with H&E. For the studies of BALB/c and NSG mice infected with 10,000 or 25 million spores, five pairs of sections, also separated by five serial sections, were prepared on slides. One slide from each pair was stained with H&E, and the other was immunohistochemically stained with a polyclonal goat antiAg2/PRA antibody that is specific for Coccidioides as previously described (21) . Historical immunohistochemically stained slides of early development of C. posadasii in mouse lungs were used for comparison (22) .
Statistical analysis. Differences in mycelial growth, spherule size, and murine survival following vaccinations were analyzed using the KruskalWallis test. The effect of hydrogen peroxide oxidative stress was analyzed by analysis of variance (ANOVA). Lung fungal burdens were log transformed and compared by ANOVA. Results were considered significant at P Յ 0.05.
Nucleotide sequence accession number. The RNA-seq data has been deposited in GEO under accession number GSE85364.
RESULTS
Deletion of the Coccidioides CPS1 gene. The C. immitis strain RS CPS1 gene (CIMG_03303.3; GenBank accession no. XM_001243861) was identified via tblastn analysis of the Coccidioides genome database using the Cochliobolus heterostrophus Cps1 protein (GenBank accession no. AF332878) (7). The CPS1 gene was deleted, via homologous recombination, in Coccidioides posadasii strain Silveira by Agrobacterium-mediated transformation (23) . Seven CPS1 deletion strains were identified out of 27 hygromycin-resistant transformed strains analyzed by PCR and DNA hybridization (data not shown). These strains contained a single insertion of the hphB gene in place of the coding sequences of the CPS1 locus, resulting in a 6.0-kb deletion of the full coding region of the CPS1 gene. CPS1 deletion strains 19, 52, and 53 were used for further analyses.
Growth characteristics in vitro of ⌬cps1 strain. The radial growth rate of ⌬cps1 and C. posadasii strains was the same for the first 7 days. Subsequently, at room temperature but not at 37°C, the ⌬cps1 strain showed a slight but significant slowing in radial growth compared to C. posadasii. At room temperature on day 14, the mean Ϯ standard deviation (SD) diameter was 4.1 Ϯ 0.1 cm for ⌬cps1 colonies compared to 4.7 Ϯ 0.1 cm for C. posadasii (P ϭ 0.014). C. posadasii cultures harvested after 4 weeks of growth yielded an average of 2.3 ϫ 10 8 CFU per plate (100 mm), while harvests of ⌬cps1 spores after 4 weeks yielded 10% that amount, 2 ϫ 10 7 CFU/plate. By 45 days, ⌬cps1 spores yielded 1.4 ϫ 10 8 CFU per plate, still less than C. posadasii. Despite these differences in growth rates and spore yields, ⌬cps1 spores were morphologically similar to those of wild-type C. posadasii. In the host, inhaled spores undergo a dimorphic shift and round up into spherules that range from 10 to 100 m in diameter. In the laboratory, we can induce spores to undergo spherulation by growing in Converse medium under 20% CO 2 at 37°C. We determined that spores of the ⌬cps1 strain initiated spherulation similar to C. posadasii, but ⌬cps1 spherules were significantly smaller than those of C. posadasii on each day measured (P Ͻ 0.001), with an increasing size disparity over time (Fig. 1) .
When the ⌬cps1 strain was grown on plates at room temperature, a dark green pigment was observed in the medium around growing colonies that was absent with C. posadasii or with transformed strains where the CPS1 deletion construct integrated ectopically. It is unclear whether the pigment observed is due to accumulation of a metabolic intermediate, as occurs in Aspergillus nidulans when the sterigmatocystin pathway is blocked (24) , or a response to stress. Sensitivity to oxidative stress was tested by exposure to H 2 O 2 , and as shown in Fig. 2 , the ⌬cps1 strain was actually less rather than more susceptible to oxidative stress than C. posadasii (P Ͻ 0.001). Irrespective of the temperature, C. posadasii was unable to grow in the presence of Ͼ2 mM H 2 O 2 , whereas ⌬cps1 colony growth diminished as the concentration increased; growth was eliminated beyond 6 mM H 2 O 2 at room temperature and 8 mM at 37°C. TLC analysis indicated the differential presence of small molecules, with the ⌬cps1 strain producing novel compounds of low polarity relative to C. posadasii (data not shown). The definition of the pigment in future studies should clarify whether it is an intermediate in a CPS1 metabolic pathway. Gene expression is modified during spherule development of the ⌬cps1 mutant. RNA-seq demonstrated changes in the expression level of many transcripts in the absence of Cps1. Figure 3 shows a volcano plot of the differentially regulated genes, with 167 genes reaching potential significance based on an uncorrected P value of 0.0005 or lower. In order to avoid spurious observations, we omitted genes with inconsistencies between biological replicates and focused on those gene changes with a q value (the Benjamini-Hochberg false discovery rate-adjusted P value) of Յ0.05. In addition, gene changes with an induction or repression of less than 2-fold were excluded. By these criteria, 33 genes were identified, of which 17 were downregulated during spherulation of the ⌬cps1 strain and 16 were upregulated (Table 2 ). Also shown in Table 2 are genes nominally identified as similar because of a total similarity of at least 50 and a query overlap of at least 50% at the amino acid level. Data are given for Saccharomyces cerevisiae because of its extensive annotation and separately for other fungal gene products deposited in GenBank. Downregulated genes include conserved fungal proteins with similarity to genes involved in metabolism (coenzyme A synthesis and pyruvate dehydrogenase), cellular respiration, gene and 37°C (black) on days 3 and 7 after inoculation of plates with a 6-mm plug. At both temperatures, C. posadasii fails to grow with concentrations Ͼ2 mM, while ⌬cps1 mutant growth diminished at higher hydrogen peroxide levels (P Ͻ 0.001).
regulation (a Ser/Thr protein kinase and a Ser/Thr protein phosphatase), cell adhesion, and conidiation. Three downregulated genes encode proteins that, based on GenBank sequences, are unique to Coccidioides alone or Coccidioides and its close relative, Uncinocarpus reesii. Genes with increased expression in the ⌬cps1 strain versus C. posadasii during spherulation include the secreted saprobic-phase member of the cerato-platanin family known as the Coccidioides heat-stable antigen (25) , three major facilitator superfamily (MFS) transporters, and two heat shock proteins. This analysis indicates that CPS1 deletion impacts multiple pathways, both regulatory and metabolic, suggesting that the gene has pleiotropic functions.
CPS1 deletion mutants are avirulent in mice. Naive B6 mice challenged with C. posadasii spores died by 19 days p.i., while all animals inoculated with 50 to 4,400 spores of the CPS1 deletion strain 52, 53, or 19 (the ⌬cps1 strain) remained healthy until scheduled sacrifice. From quantitative cultures of lungs of the 40 mice inoculated with strain 19, only a single colony was recovered from one mouse inoculated with 810 spores. All lungs from mice infected with strains 52 and 53 were sterile. No fungus grew from the spleens of any of these mice. PCR analysis of the single colony recovered from a mouse given the ⌬cps1 strain verified that it was the mutant strain (data not shown). Supporting the lack of growth from nearly all mice, histopathology of two mice from each group infected with any of the CPS1 deletion strains revealed no spherules or inflammation in lung sections, while innumerable spherules invaded 50 to 80% of lung tissue from C. posadasii-infected mice or mice infected with strain 45, the one with the ectopic insertion of the CPS1 deletion construct.
To further assess the avirulence noted in B6 mice, we inoculated six immunocompromised NSG mice intranasally with 1,030 ⌬cps1 spores. An equivalent dose of C. posadasii spores would be lethal to immunocompetent mice within 10 days of infection. NSG mice appeared healthy until sacrifice, including the four animals kept for 2 weeks. Histology of step sections through the entire lungs of 2 mice each on days 6 and 14 p.i. revealed no spherules. However, while lung cultures of one mouse at day 14 p.i. had no fungal growth, the other grew 8,200 CFU, demonstrating the capacity of the mutant strain to persist for at least 14 days while not causing illness. PCR of selected colonies verified the gene deletion.
Because we were unable to observe the mutant spherules histologically with a 1,000-spore inoculation yet the culture-positive mouse supported at least transient growth of the strain, we inoculated two NSG and two BALB/c mice with 10,000 ⌬cps1 spores and sacrificed one each on days 1 and 3 p.i. to look earlier and with a 10-fold higher inoculum. With this infectious dose, no abnormalities were seen on day 1 p.i., and only a few spherules were visualized in both strains on day 3 p.i. (a maximum of 11 spherules per 200ϫ field in the NSG mouse and 4 in the BALB/c mouse), ranging from 0 to approximately two dozen per slide. Organisms were unevenly distributed in the lungs, and most fields were devoid of spherules in both strains. The ⌬cps1 spherules generally appeared empty with thin, irregular, and broken walls. They were often degraded and surrounded by or filled with neutrophils (Fig.  4A ). This was in contrast to 3-day C. posadasii spherules in historical controls, which are characterized by thick walls, uniform roundness, and internal content (endospores) which reacts strongly with the Coccidioides-specific stain. The C. posadasii spherules have a mild macrophage infiltrate surrounding them but few or no neutrophils (Fig. 4B) . Following identification of spherules by Coccidioides-specific staining, evaluation of the H&E slides from the NSG and BALB/c mice at higher power (600ϫ) better demonstrated the neutrophilic inflammation in and around the broken, empty ⌬cps1 spherules (Fig. 4C) .
Because of the paucity of spherules seen following the 10,000-spore infection of BALB/c and NSG mice and the degraded appearance of the spherules at day three, BALB/c mice were infected with a very high dose of ⌬cps1 spores (2.5 ϫ 10 7 ) and their lungs were studied starting 1 day after infection. H&E-stained sections from day one p.i. revealed suppurative bronchopneumonia with edema, but no organisms were seen. The huge inflammatory response was presumed to be a reaction to the large number of foreign particles instilled in the lungs. By day three, we observed extensive suppurative bronchial and alveolar infiltrates with large numbers of ⌬cps1 spherules, most of which appeared degenerated with neutrophilic inflammation within and surrounding them. Endospores were infrequently observed in the ⌬cps1 spherules on days four and five, and among these we observed a failure of the ⌬cps1 endospores to disperse and a dense accumulation of neutrophils surrounding them (Fig. 5A) . In contrast, in wild-type infections, endospores were dispersing both individually and in clusters with a mixed inflammatory response more loosely aggregated between them (Fig. 5B) .
Lungs from the two high-dose ⌬cps1 mutant-infected mice sacrificed on days 7 and 10 had a Ͼ90% visual decrease in spher- posadasii and ⌬cps1 strains, while blue dots indicate significant difference. There were 167 genes reaching potential significance based on an uncorrected P value of 0.0005 or lower. In order to avoid spurious observations, we omitted genes with inconsistencies between biological replicates and focused on 33 differentially expressed genes with a q value (the Benjamini-Hochberg false discovery rate-adjusted P value) of Ͻ0.05 or lower. ules compared to the day five lungs (data not shown). Small, sporadic lesions were characterized as mature granulomas with a fibrogranulomatous mantle and a necrotic center of debris, degenerate and nondegenerate neutrophils, and occasional small, empty spherules. In summary, these highly susceptible BALB/c mice had almost completely resolved this extreme dose (approximately 5 logs higher than the lethal dose of the C. posadasii strain) within 7 to 10 days p.i. Immunization with the ⌬cps1 strain provides protection against infection by wild-type C. posadasii. Following vaccination with the ⌬cps1 strain or controls, B6 mice were infected with the lethal dose of 90 C. posadasii spores. After 14 days, they were clinically well, and cultures revealed that the ⌬cps1 mutant viable spore vaccination provided a highly significant reduction in lung fungal burden, 3 logs less than mice receiving the chimeric antigen (P Ͻ 0.001) and almost 5 logs less than those receiving the adjuvant alone (P Ͻ 0.001) (Fig. 6) . Mice in the control group had a mean lung fungal burden of 5.3 ϫ 10 7 CFU (range, 8.0 ϫ 10 2 to 11.9 ϫ 10 7 CFU), while the mean fungal burden of all mice vaccinated with the ⌬cps1 strain was 2.1 ϫ 10 2 CFU (range, 1 to 1.7 ϫ 10 3 CFU).
Vaccination with the ⌬cps1 strain of the more susceptible BALB/c mice, either i.n. or s.c., and infection with 46 C. posadasii spores resulted in 19 of 20 mice surviving until day 28 p.i., while control mice that received the chimeric antigen vaccine or adjuvant only all died by day 15 p.i. (P Ͻ 0.001) (Fig. 7A) . As shown in Fig. 7B , the lung fungal burdens of surviving ⌬cps1 strain-vaccinated BALB/c mice at 28 days p.i. was less than 1,000 CFU per lung for 18 of 19 mice, with 7 producing no growth from their lungs. Fungal burden was not measured in the mouse that died before day 28. Although fungal burdens were lower in the i.n. than in the s.c. ⌬cps1 strain-vaccinated groups, differences were not significant (P ϭ 0.241). One animal from the ⌬cps1 strain s.c. vaccinated group lost weight during the last week and was found to have 4.6 ϫ 10 4 CFU in the lungs, and spleen cultures were positive when the animal was euthanized. With this one exception, spleen cultures were negative in ⌬cps1 strain-vaccinated mice, indicating the vaccine also prevented fungal dissemination. Spleens from the recombinant vaccine and adjuvant groups that died were universally positive for fungal growth. Thus, ⌬cps1 strain vaccination is highly effective in preventing disease or death from respiratory coccidioidal infection in both B6 and BALB/c mice.
DISCUSSION
In this report, we used data about a virulence factor in the phytopathogen C. heterostrophus (7) as the basis for our discovery that the CPS1 gene in C. posadasii is essential to its pathogenicity in mice. While in C. heterostrophus CPS1 mutations result in only a partial reduction in lesion size on maize (7), deletion of CPS1 in Coccidioides virtually eliminated its pathogenicity in mice, even at high intranasal inocula or in immunodeficient mice. This is a dramatic example of using virulence gene discovery in a fungal phytopathogen as the point of discovery for a critical virulence factor in a medically important fungus.
CPS1 is highly conserved among the Ascomycota with genes of high similarity also present in lower fungi, although they apparently are absent from the Basidiomycota (data not shown).
Experimental evidence of the function of CPS1 genes in ascomycetes is lacking. By motif analysis, CPS1 in C. heterostrophus was shown to belong to the AMP-binding superfamily and phylogenetic analysis initially suggested it could be part of a nonribosomal peptide synthase (NRPS) (7), but further evidence suggests it groups outside most NRPSs (26) . CPS1 is part of the adenylate forming domain superfamily of proteins that includes the disco- interacting proteins (Dip2), such as DIP2 of Drosophila and Dip2A in mice and humans (27) (28) (29) . Dip2A is a membrane receptor protein that binds secreted follistatin-like proteins which appear to regulate downstream gene expression. Like the Dip2 proteins, Cps1 contains a DMAP1 binding domain at its N terminus, with DMAP being a transcriptional corepressor. In silico analysis of Cps1 suggests it is also a transmembrane protein, indicating it functions by interacting with an extracellular signal, resulting in a cellular response. In C. posadasii, our RNA-seq analysis is also consistent with a regulatory role for Cps1, since multiple genes and pathways are impacted by CPS1 deletion. The differential appearance of products between WT and ⌬cps1 strains during saprobic growth using TLC analysis indicates modified metabolism upon deletion of CPS1. Detailed analysis of these products could shed light on the biochemical consequences of the CPS1 deletion. What little is known or hypothesized about the function of Cps1 at this time does not explain the level of avirulence observed in mice infected with the ⌬cps1 strain. Although deletion of CPS1 resulted in a modest reduction of both saprobic and first-generation spherule growth in vitro, those assays showed that it is competent to make spores and to transform into spherules. The mutant (i) has a mycelial radial growth rate similar to that of C. posadasii initially but shows retarded growth after 2 weeks and (ii) sporulates at a reduced rate, producing 10% of the spores of C. posadasii after 30 days, and still a reduced number of spores compared to C. posadasii at 45 days. Finally, in vitro spherules are reduced in size by about 25% at 72, 96, and 120 h. Because initial studies in mice showed complete avirulence and failed to identify inflammation or residual organisms in 39/40 mice, it was unknown whether the ⌬cps1 strain was unable to make the dimorphic switch in the host or if it was very susceptible to the host immune system. Histopathological observations at early time points and in NSG mice lacking adaptive components of their immune system demonstrated that (i) the ⌬cps1 strain does undergo spherulation in the host; (ii) the vast majority of the organisms appear to degrade with or without the presence of the host immune system; and (iii) near complete clearance of even large inocula from the lungs occurs within 10 days in susceptible but immunocompetent mice. These observations strongly indicate that the attenuation of the ⌬cps1 strain does not depend upon an unusual susceptibility to host immunologic defenses but rather that the ⌬cps1 strain is simply unfit for propagation within mammalian tissue. If corroborated by further studies, such as clearance of high inocula from the lungs of immunodeficient mice, this characteristic has profound implications for the possible safety of the ⌬cps1 strain as a vaccine candidate.
When used as a vaccine, the ⌬cps1 strain produced exceptional protection against subsequent C. posadasii infection, measured both by dramatically enhanced survival and reduction in fungal burden, regardless of parenteral i.p. and s.c. or i.n. routes of administration. In BALB/c mice, 95% or greater survival was observed following either subcutaneous or intranasal immunization. Notably, a recombinant vaccine, which in past studies was found to be protective in C75BL/6 mice (20), showed no prolongation in survival under these conditions. In going forward with a vaccine, these model studies have demonstrated that a subcutaneous route of administration, practical for humans and dogs, is just as effective as other routes.
The ⌬cps1 strain is not the first attenuated Coccidioides mutant to protect mice when used as a vaccine. Subcutaneous but not intranasal vaccination with temperature-sensitive mutants protected against intranasal infection (30) . Protection also was produced by another live attenuated mutant created by the deletion of two of the eight C. posadasii chitinases (CTS2 and CTS3) and disruption of a third gene (ARD1) contiguous to CTS3 (31) . Of note, both the ⌬cps1 strain and the previously published live attenuated vaccines initiated spherule development before growth was arrested. In contrast, vaccination of mice with an RYP1 knockout strain of C. posadasii, which does not undergo transition to the spherule phase in C. posadasii (32) , did not induce protection to a subsequent coccidioidal infection (M. A. Mandel, M. J. Orbach, and L. F. Shubitz, unpublished data). In earlier studies, spherule vaccines were found to be protective against respiratory murine coccidioidal infections whereas mycelial vaccines were not (33) . This pattern is consistent with the possibility that spherule initiation as occurs in the ⌬cps1 strain is critical for a live vaccine to stimulate protective immunity against a respiratory infection.
The search for a clinically useful vaccine to prevent coccidioidomycosis has been ongoing for over half a century (34) . Whole killed spherule vaccines provided excellent protection in mice when given repetitively in milligram quantities, but injection site reactions were severe, including caseous granulomas that sometimes produced skin breakdown. Protection from this vaccine was sufficiently impressive in mice to merit human trials, but at a dose that was protective in mice, adverse injection site reactions in humans were severe (35) and no differences were seen in incidence of Valley Fever in vaccinated and control populations (36) . Because of this, lower doses of whole-cell preparations or specific subcellular components seemed necessary for a tenable vaccine. The chimeric peptide recombinant vaccine used in this study for comparisons to the ⌬cps1 strain was a potential subcellular candidate. It was proposed by a large collaborative program as a vaccine candidate for use in clinical trials because of its protection in B6 mice (20) despite its limitations in BALB/c mice, as shown here. Those trials were never conducted, in large part because the cost of manufacturing and formulation were prohibitive for a small-market vaccine such as one to prevent coccidioidomycosis. Such practical considerations make the ⌬cps1 strain particularly attractive as a vaccine candidate for clinical development. Spores, as used in our murine studies, are, in essence, the vaccine formulation. It would still be necessary to develop methods to harvest spores and dispense them into stable and storable units. However, identifying and applying industrial technologies for managing fungal spores would seem to be a much less difficult requirement and more feasible than the formulation required for a polypeptide vaccine to allow clinical trials to proceed. Although our ultimate objective is to use the ⌬cps1 strain as a vaccine to prevent coccidioidomycosis in humans, there is a similar need for a canine vaccine (37), and we hope to achieve that goal as well.
